Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Cellular Oncology
Erschienen in: Cellular Oncology 5/2018

25.07.2018 | Review

Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression

verfasst von: Kaumudi Bhawe, Deodutta Roy

Erschienen in: Cellular Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Nuclear respiratory factor 1 (NRF1), historically perceived as a protein regulating genes controlling mitochondrial biogenesis, is now widely recognized as a multifunctional protein and as a key player in the transcriptional modulation of genes implicated in various cellular functions. Here, we present emerging data supporting novel roles of NRF1 in cancer development and progression through its interplay with the transcription factors E2F4 and MYC. To identify common human NRF1, E2F4 and MYC target genes, we analyzed the Encyclopedia of DNA Elements (ENCODE) NRF1 ChIP-Seq data. By doing so, we identified 9253 common target genes with NRF1, E2F4 and MYC binding motifs. NRF1 binding motifs were found to be present in genes operating in signaling pathways governing all hallmarks of malignant transformation and progression, including proliferation, invasion, self-renewal and apoptosis.

Conclusions

In addition to controlling mitochondrial biogenesis NRF1, in conjunction with E2F4 and MYC, may play a critical role in the acquisition of human cancer characteristics. Additionally, NRF1 may orchestrate both MYC and E2F4 to regulate common target genes linked to multiple networks in the development and progression of cancer. A comprehensive understanding of this dynamic interplay will set the stage, not only for the design of novel treatment strategies, but also for the discovery of pan-cellular transcription factor regulatory strategies to predict cancer risk, therapy response and patient prognosis.
Literatur
1.
2.
S.A. Lambert, A. Jolma, L. Campitelli, P. Das, T. Yin, M. Albu, X. Chen, J. Taipale, T. Hughes, M. Weirauch, The human transcription factors. Cell 172, 650–665 (2018)PubMedCrossRef
3.
M.M. Falco, M. Bleda, J. Carbonell-Caballero, J. Dopazo, The pan-cancer pathological regulatory landscape. Nature Sci Rep 6 (2016)
4.
5.
V.O. Okoh, Q. Felty, J. Parkash, R. Poppiti, D. Roy, Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One 8, e54206 (2011)CrossRef
6.
V.O. Okoh, N.A. Garba, R.B. Penney, J. Das, A. Deoraj, K. Singh, S. Sarkar, Q. Felty, C. Yoo, R. Jackson, D. Roy, Redox signaling to nuclear regulatory proteins by reactive oxygen species contributes to estrogen-induced growth of breast cancer cells. British J Cancer 112, 1687–1702 (2015)CrossRef
7.
D. Roy, R. Tamuli, NRF1 (nuclear respiratory factor 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology 13, 4 (2008)
8.
L. Gopalakrishnan, R.C. Scarpulla, Structure, expression, and chromosomal assignment of the human gene encoding nuclear respiratory factor 1. J Biol Chem 270, 18019–18025 (1995)PubMedCrossRef
9.
R.C. Scarpulla, Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88, 611–638 (2008)PubMedCrossRef
10.
J.Y. Chan, X.L. Han, Y.W. Kan, Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A 90, 11371–11375 (1993)PubMedPubMedCentralCrossRef
11.
V. Tiranti, E. Rossi, M. Rocchi, S. DiDonato, O. Zuffardi, M. Zeviani, The gene (NFE2L1) for human NRF-1, an activator involved in nuclear-mitochondrial interactions, maps to 7q32. Genomics 27, 555–557 (1995)PubMedCrossRef
12.
R.C. Scarpulla, Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci 1147, 321–334 (2008)PubMedPubMedCentralCrossRef
13.
J.S. Bassey, J.A.C. Efiok, B. Safer, A key transcription factor for eukaryotic initiation factor-2a is strongly homologous to developmental transcription factors and may link metabolic genes to cellular growth and development. J Biol Chem 269, 18921–18930 (1994)
14.
H. Cam, E. Balciunaite, A. Blais, A. Spektor, R.C. Scarpulla, R. Young, Y. Kluger, B.D. Dynlacht, A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16, 399–411 (2004)PubMedCrossRef
15.
J. Satoh, N. Kawana, Y. Yamamoto, Pathway analysis of ChIP-Seq-based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogenesis of neurodegenerative diseases. Gene Reg Syst Biol 7, 139–152 (2013)
16.
17.
A.L. Gartel, K. Shchors, Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283, 17–21 (2003)PubMedCrossRef
18.
B. Lüscher, Function and regulation of the transcription factors of the Myc/max/mad network. Gene 277, 1–14 (2001)PubMedCrossRef
19.
C.V. Dang, S.B. McMahon, Emerging concepts in the analysis of transcriptional targets of the MYC oncoprotein: Are the targets targetable? Genes & Cancer 1, 560–567 (2010)CrossRef
20.
W. Tansey, P. Mammalian, MYC proteins and cancer. New Journal of Science, Hindawi 757534, 1–27 (2014)
21.
H.Z. Chen, S.Y. Tsai, G. Leone, Emerging roles of E2Fs in cancer: An exit from cell cycle control. Nature Rev Cancer 9, 785–797 (2009)CrossRef
22.
S. Schwemmle, P. Pfeifer, Genomic structure and mutation screening of the E2F4 gene in human tumors. Int J Cancer 86, 672–677 (2000)PubMedCrossRef
23.
24.
S. Skirnisdottir, G. Eiriksdottir, T. Baldursson, R.B. Barkardottir, V. Egilsson, S. Ingvarrson, High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: Correlation with high PgR and low S phase. Int J Cancer 64, 112–116 (1995)PubMedCrossRef
25.
X. Zhong, H. Hemmi, J. Koike, K. Tsujita, H. Shimatake, Various AGC repeat numbers in the coding region of the human transcription factor gene E2F-4. Hum Mut 15, 296–297 (1999)CrossRef
26.
N. Palmer, P. Kaldis, Regulation of the embryonic cell cycle during mammalian preimplantation development. Curr Top Dev Biol 120, 1–53 (2016)PubMedCrossRef
27.
Z. Kherrouche, D.Y. Launoit, D. Monte, The NRF-1/α-PAL transcription factor regulates human E2F6 promoter activity. Biochem J 383, 529–536 (2004)PubMedPubMedCentralCrossRef
28.
S.T. Shors, B.J.S. Effiok, S.J. Harkin, B. Safer, Formation of pal/max heterodimers synergistically activates the eif2 promoter. J Biol Chem 273, 529–536 (1998)CrossRef
29.
A.B. West, G. Kapatos, C. O’Farrell, F. Gonzalez-de-Chavez, K. Chiu, M.J. Farrer, N.T. Maidment, N-myc regulates parkin expression. J Biol Chem 279, 28896–28902 (2004)PubMedCrossRef
30.
J.K. Das, D. Roy, Transcriptional regulation of chemokine receptor 4 (CXCR4) by nuclear respiratory factor 1 (NRF1) controls estrogen-induced malignant transformation of breast epithelial cells to breast cancer stem cells. Cancer Res 76, 3312 (2016)CrossRef
31.
J.M. Lin, P.J. Collins, N.D. Trinklein, Y. Fu, H. Xi, R.M. Myers, Z. Weng, Transcription factor binding and modified histones in human bidirectional promoters. Genome Res 17, 818–827 (2007)PubMedPubMedCentralCrossRef
32.
Y.M. Oh, J.K. Kim, S. Choi, J.Y. Yoo, Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices. Nucl Acids Res 40, e38–e38 (2012)PubMedCrossRef
33.
R. Elkon, C. Linhart, R. Sharan, R. Shamir, Y. Shiloh, Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13, 773–780 (2003)PubMedPubMedCentralCrossRef
34.
C. Benner, S. Konovalov, C. Mackintosh, K.R. Hutt, R. Stunnenberg, I. Garcia-Bassets, Decoding a signature-based model of transcription cofactor recruitment dictated by cardinal cis-regulatory elements in proximal promoter regions. PLoS Genet 9, e1003906 (2013)PubMedPubMedCentralCrossRef
35.
R.I. Sherwood, T. Hashimoto, C.W. O'Donnell, S. Lewis, A.A. Barkal, J.P. van Hoff, V. Karun, T. Jaakkola, D.K. Gifford, Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape. Nature Biotech 32, 171–178 (2014)CrossRef
36.
M.D. Lavigne, G. Vatsellas, A. Polyzos, E. Mantouvalou, G. Sianidis, I. Maraziotis, M. Agelopoulos, D. Thanos, Composite macroH2A/NRF-1 nucleosomes suppress noise and generate robustness in gene expression. Cell Rep 11, 1090–1101 (2015)PubMedCrossRef
37.
A. Ferraro, Altered primary chromatin structures and their implications in cancer development. Cell Oncol 39, 195–210 (2016)CrossRef
38.
39.
H.B. Suliman, J.E. Keenan, C.A. Piantadosi, Mitochondrial quality-control dysregulation in conditional HO-1−/− mice. JCI Insight 2, e89676 (2017)PubMedPubMedCentralCrossRef
40.
C. Zhang, M. Lin, R. Wu, X. Wang, B. Yang, A.J. Levine, W. Hu, Z. Feng, Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A 108, 16259–16264 (2011)PubMedPubMedCentralCrossRef
41.
A. Soufi, G. Donahue, K.S. Zaret, Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994–1004 (2012)PubMedPubMedCentralCrossRef
42.
J.D. Lin, Minireview: The PGC-1 coactivator networks: Chromatin-remodeling and mitochondrial energy metabolism. Mol Endocrin 23, 2–10 (2009)CrossRef
43.
W.-S. Tzou, Identification of potential E2F target genes through cis-regulatory modules derived from chromatin immunoprecipitation microarray data. Fooyin J Health Sci 2, 66–70 (2010)CrossRef
44.
H. Liu, X. Tang, A. Srivastava, T. Pecot, P. Daniel, B. Hemmelgarn, S. Reyes, N. Fackler, A. Bajwa, R. Kladney, C. Koivisto, Z. Chen, Q. Wang, K. Huang, R. Machiraju, M.T. Saenz-Robles, P. Cantalupo, J.M. Pipas, G. Leone, Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nature Cell Biol 17, 1036–1048 (2015)PubMedCrossRef
45.
C.R. Chen, Y. Kang, P.M. Siegel, J. Massagué, E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell 110, 19–32 (2002)PubMedCrossRef
46.
H. Ogawa, K.I. Ishiguro, S. Gaubatz, D.M. Livingston, Y. Nakatani, A complex with chromatin modifiers that occupies E2F and Myc responsive genes in G0 cells. Science 296, 1132–1136 (2002)PubMedCrossRef
47.
R.E. Rempel, S. Mori, M. Gasparetto, M.A. Glozak, E.R. Andrechek, S.B. Adler, N.M. Laakso, A.S. Lagoo, R. Storms, C. Smith, J.R. Nevins, A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. PLoS Genet 5, e1000640 (2009)PubMedPubMedCentralCrossRef
48.
A. Fortunato, The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. Cell Oncol 40, 367–378 (2017)CrossRef
49.
A. Sathyanarayanan, K.S. Chandrasekaran, D. Karunagaran, microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Cell Oncol 40, 119–131 (2017)CrossRef
50.
S. Bugide, V.K. Gonugunta, V. Penugurti, V.L. Malisetty, R.K. Vadlamudi, B. Manavathi, HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Cell Oncol 40, 133–144 (2017)CrossRef
51.
M. Mohrin, J. Shin, Y. Liu, K. Brown, H. Luo, Y. Xi, C.M. Haynes, D. Chen, Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging. Science 347, 1374–1377 (2015)PubMedPubMedCentralCrossRef
52.
J. Vazquez, J. Das, D. Roy, Estrogen and nuclear respiratory factor 1 act as joint mediators of redox modulation and stem cell aging that contribute in the pathogenesis of breast cancer. Cancer Res 76, 3322 (2016)CrossRef
53.
K. Bhawe, J. Das, C. Yoo, and D. Roy, NRF1 regulated gene-network characterizing chemical toxicity through TF effects in brain cancer. In: The Toxicologist: Supplement to Toxicological Sciences, 150, Abstract No. 1961, Pp 234, (2018)
54.
M. Preciados, C. Yoo, D. Roy, Estrogenic endocrine disrupting chemicals influencing NRF1 regulated gene networks in the development of complex human brain diseases. Int J Mol Sci 17, E2086 (2016)PubMedCrossRef
55.
J. Wang, H. Wang, Z. Li, Q. Wu, J.D. Lathia, R.E. McLendon, A.B. Hjelmeland, J.N. Rich, C-Myc is required for maintenance of glioma cancer stem cells. PLoS One 3, e3769 (2008)PubMedPubMedCentralCrossRef
56.
57.
S. Galardi, M. Savino, F. Scagnoli, S. Pellegatta, F. Pisati, F. Zambelli, B. Illi, D. Annibali, S. Beji, E. Orecchini, M.A. Alberelli, C. Apicella, R.A. Fontanella, A. Michienzi, G. Finocchiaro, M.G. Farace, G. Pavesi, S.A. Ciafrè, S. Nasi, Resetting cancer stem cell regulatory nodes upon MYC inhibition. EMBO Rep 17, 1872–1889 (2016)PubMedPubMedCentralCrossRef
58.
R. Scognamiglio, N. Cabezas-Wallscheid, M.C. Thier, S. Altamura, A. Reyes, A.M. Prendergast, D. Baumgartner, L.S. Carnevalli, A. Atzberger, S. Haas, L. von Paleske, T. Boroviak, P. Worsdorfer, M.A. Essers, U. Kloz, R.N. Eisenman, F. Edenhofer, P. Bertone, W. Huber, F. van der Hoeven, A. Smith, A. Trumpp, Myc depletion induces a pluripotent dormant state mimicking diapause. Cell 164, 668–680 (2016)PubMedPubMedCentralCrossRef
59.
H.C. Yeo, T.T. Beh, J.J. Quek, G. Koh, K.K. Chan, D.Y. Lee, Integrated transcriptome and binding sites analysis implicates E2F in the regulation of self-renewal in human pluripotent stem cells. PLoS One 6, e27231 (2011)PubMedPubMedCentralCrossRef
60.
61.
S. Pauklin, P. Madrigal, A. Bertero, L. Vallier, Initiation of stem cell differentiation involves cell cycle-dependent regulation of developmental genes by cyclin D. Genes Dev 30, 421–433 (2016)PubMedPubMedCentralCrossRef
62.
A. Diman, F. Poulain, J. Rodriguez, M. Purnelle, H. Episkopou, L. Bertrand, M. Francaux, L. Deldicque, A. Decottignies, Nuclear respiratory factor 1 and endurance exercise promote human telomere transcription. Science Adv 2, e1600031 (2016)CrossRef
63.
64.
J.W. Hofmann, X. Zhao, M. De Cecco, A.L. Peterson, L. Pagliaroli, J. Manivannan, G.B. Hubbard, Y. Ikeno, Y. Zhang, B. Feng, X. Li, T. Serre, W. Qi, H. Van Remmen, R.A. Miller, K.G. Bath, R. de Cabo, H. Xu, N. Neretti, J.M. Sedivy, Reduced expression of MYC increases longevity and enhances healthspan. Cell 160, 477–488 (2015)PubMedPubMedCentralCrossRef
65.
66.
C. Park, I. Lee, W.K. Kang, E2F-1 is a critical modulator of cellular senescence in human cancer. Int J Mol Med 17, 715–720 (2006)PubMed
67.
P. Iakova, S.S. Awad, N.A. Timchenko, Aging reduces proliferative capacities of liver by switching pathways of C/EBP growth arrest. Cell 113, 495–506 (2003)PubMedCrossRef
68.
M. Vernier, V. Bourdeau, M.F. Gaumont-Leclerc, O. Moiseeva, V. Begin, F. Saad, A.M. Mes-Masson, G. Ferbeyre, Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 25, 41–50 (2011)PubMedPubMedCentralCrossRef
69.
J. Permuth-Wey, Y.A. Chen, Y.Y. Tsai, Z. Chen, X. Qu, J.M. Lancaster, H. Stockwell, G. Dagne, E. Iversen, H. Risch, J. Barnholtz-Sloan, J.M. Cunningham, R.A. Vierkant, B.L. Fridley, R. Sutphen, J. McLaughlin, S.A. Narod, E.L. Goode, J.M. Schildkraut, D. Fenstermacher, C.M. Phelan, T.A. Sellers, Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol Biomark Prev 20, 1131–114567 (2011)CrossRef
70.
W. Liu, B.H. Beck, K.S. Vaidya, K.T. Nash, K.P. Feeley, S.W. Ballinger, K.M. Pounds, W.L. Denning, A.R. Diers, A. Landar, A. Dhar, T. Iwakuma, D.R. Welch, Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Res 74, 954–963 (2014)PubMedCrossRef
71.
M.M. Ivanova, K.H. Luken, A.S. Zimmer, F.L. Lenzo, R.J. Smith, M.W. Arteel, T.J. Kollenberg, K.A. Mattingly, C.M. Klinge, Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP-1 recruitment to adjacent promoter binding sites. FASEB J 25, 1402–1416 (2011)PubMedPubMedCentralCrossRef
72.
D. Wang, J. Zhang, Y. Lu, Q. Luo, L. Zhu, Nuclear respiratory factor (NRF1) regulated hypoxia inducible factor 1alpha (HIF1a) under hypoxia in HEK293T. IUBMB Life 68, 748–755 (2016)PubMedCrossRef
73.
L. Zhang, Q. Ding, Z. Wang, Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner. PLoS One 7, e42035 (2012)PubMedPubMedCentralCrossRef
74.
A.G. Vaiopoulos, K. Athanasoula, A.G. Papavassiliou, Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges. Biochim Biophys Acta 1842, 971–980 (2014)PubMedCrossRef
75.
S. Sharma Saha, R. Roy Chowdhury, N.R. Mondal, B. Chakravarty, T. Chatterjee, S. Roy, S. Sengupta, Identification of genetic variation in the lncRNA HOTAIR associated with HPV16-related cervical cancer pathogenesis. Cell Oncol 39, 583–589 (2016)CrossRef
76.
M. Xu, C.E. Cross, J.T. Speidel, S.Z. Abdel-Rahman, MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression. Cell Oncol 39, 435–447 (2016)CrossRef
77.
C. Gebhard, C. Benner, M. Ehrich, L. Schwarzfischer, E. Schilling, M. Klug, W. Dietmaier, C. Thiede, E. Holler, R. Andreesen, M. Rehli, General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res 70, 1398–1407 (2010)PubMedCrossRef
78.
79.
80.
H. Liu, D.C. Radisky, D. Yang, R. Xu, E.S. Radisky, M.J. Bissell, J.M. Bishop, MYC suppresses cancer metastasis by direct transcriptional silencing of [alpha]v and [beta]3 integrin subunits. Nature Cell Biol 14, 567–574 (2012)PubMedCrossRef
81.
M. Jung, A.J. Russell, B. Liu, J. George, P.Y. Liu, T. Liu, A. DeFazio, D.D. Bowtell, A. Oberthuer, W.B. London, J.I. Fletcher, M. Haber, M.D. Norris, M.J. Henderson, A Myc activity signature predicts poor clinical outcomes in Myc-associated cancers. Cancer Res 15, 971–981 (2017)CrossRef
82.
U.R. Rapp, C. Korn, F. Ceteci, C. Karreman, K. Luetkenhaus, V. Serafin, E. Zanucco, I. Castro, T. Potapenko, MYC is a metastasis gene for non-small-cell lung cancer. PLoS One 4, e6029 (2009)PubMedPubMedCentralCrossRef
83.
L. Fagnocchi, A. Cherubini, H. Hatsuda, A. Fasciani, S. Mazzoleni, V. Poli, V. Berno, R. Rossi, R. Reinbold, M. Endele, T. Schroeder, M. Rocchigiani, Z. Szkarlat, S. Oliviero, S. Dalton, A. Zippo, A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity. Nat Commun 7, 11903 (2016)PubMedPubMedCentralCrossRef
84.
H.B. Suliman, T.E. Sweeney, C.M. Withers, C.A. Piantadosi, Co-regulation of nuclear respiratory factor-1 by NFkappaB and CREB links LPS-induced inflammation to mitochondrial biogenesis. J Cell Science 123, 2565–2575 (2010)PubMedCrossRef
85.
86.
87.
T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, K.M. West, C.V. Dang, A. Thomas-Tikhonenko, J.T. Mendell, Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet 40, 43–50 (2008)PubMedCrossRef
88.
C. Bertoli, J.M. Skotheim, R.A. de Bruin, Control of cell cycle transcription during G1 and S phases. Nature Rev Mol Cell Biol 14, 518–528 (2013)CrossRef
89.
G. Yao, Modelling mammalian cellular quiescence. Interface Focus 4, 3 (2014)CrossRef
90.
S. Zheng, J. Moehlenbrink, Y.C. Lu, L.P. Zalmas, C.A. Sagum, S. Carr, J.F. McGouran, L. Alexander, O. Fedorov, S. Munro, B. Kessler, M.T. Bedford, Q. Yu, N.B.L. Thangue, Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1. Mol Cell 52, 37–51 (2013)PubMedPubMedCentralCrossRef
91.
B.P. Coe, K.L. Thu, S.A. Ronen, E.A. Vucic, A.F. Gazdar, S. Lam, M.S. Tsao, W.L. Lam, Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. PLoS One 8, e71670 (2013)PubMedPubMedCentralCrossRef
92.
H.Z. Chen, M.M. Ouseph, J. Li, T. Pécot, V. Chokshi, L. Kent, S. Bae, M. Byrne, C. Duran, G. Comstock, P. Trikha, M. Mair, S. Senapati, C.K. Martin, S. Gandhi, N. Wilson, B. Liu, Y.W. Huang, J.C. Thompson, S. Raman, S. Singh, M. Leone, R. Machiraju, K. Huang, X. Mo, S. Fernandez, I. Kalaszczynska, D.J. Wolgemuth, P. Sicinski, T. Huang, V. Jin, G. Leone, Canonical and atypical E2Fs regulate the mammalian endocycle. Nature Cell Biol 14, 1192–1202 (2012)PubMedCrossRef
93.
J. Johnson, B. Thijssen, U. McDermott, M. Garnett, L.F.A. Wessels, R. Bernards, Targeting the RB-E2F pathway in breast cancer. Oncogene 35, 4829–4835 (2016)PubMedPubMedCentralCrossRef
94.
D.P. Hollern, J. Honeysett, R.D. Cardiff, E.R. Andrechek, The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol 34, 3229–3240 (2014)PubMedPubMedCentralCrossRef
95.
E.R. Andrechek, HER2/Neu tumorigenesis and metastasis is regulated by E2F activator trancription factors. Oncogene 34, 217–225 (2015)PubMedCrossRef
96.
A. Mathe, M.W. Brown, B. Morten, J.F. Forbes, S.G. Braye, K.A. Avery-Kiejda, R.J. Scott, Novel genes associated with lymph node metastasis in triple negative breast cancer. Nature Sci Rep 5, 15832 (2015)
97.
H. Garneau, L. Alvarez, M.C. Paquin, C. Lussier, C. Rancourt, E. Tremblay, J.F. Beaulieu, N. Rivard, Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 293, G758–G772 (2007)PubMedCrossRef
98.
D. Dingar, F. Konecny, J. Zou, X. Sun, R. von Harsdorf, Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes. J Mol Cell Cardiol 53, 820–828 (2007)CrossRef
99.
L. Zhao, M. Tang, Z. Hu, B. Yan, W. Pi, Z. Li, J. Zhang, L. Zhang, W. Jiang, G. Li, Y. Qiu, F. Hu, F. Liu, J. Lu, X. Chen, L. Xiao, Z. Xu, Y. Tao, L. Yang, A.M. Bode, Z. Dong, J. Zhou, J. Fan, L. Sun, & Cao Y. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Oncotarget 6, 15995–16018 (2015)PubMedPubMedCentral
100.
R.B. Penney, D. Roy, Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochim Biophys Acta 1836, 60–79 (2013)PubMed
101.
B.N. Radde, M.M. Ivanova, H.X. Mai, N. Alizadeh-Rad, K. Piell, P. Van Hoose, M.P. Cole, P. Muluhngwi, T.S. Kalbfleisch, E.C. Rouchka, B.G. Hill, C.M. Klinge, Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells. Exp Cell Res 347, 222–231 (2016)PubMedPubMedCentralCrossRef
102.
G. Zhang, D.T. Frederick, L. Wu, Z. Wei, C. Krepler, S. Srinivasan, Y.C. Chae, X. Xu, H. Choi, E. Dimwamwa, O. Ope, B. Shannan, D. Basu, D. Zhang, M. Guha, M. Xiao, S. Randell, K. Sproesser, W. Xu, J. Liu, G.C. Karakousis, L.M. Schuchter, T.C. Gangadhar, R.K. Amaravadi, M. Gu, C. Xu, A. Ghosh, W. Xu, T. Tian, J. Zhang, S. Zha, Q. Liu, P. Brafford, A. Weeraratna, M.A. Davies, J.A. Wargo, N.G. Avadhani, Y. Lu, G.B. Mills, D.C. Altieri, K.T. Flaherty, M. Herlyn, Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest 126, 1834–1856 (2016)PubMedPubMedCentralCrossRef
103.
M.H. Uddin, B. Kim, D.H. Suh, Y.S. Song, Anticancer strategy targeting mitochondrial biogenesis in ovarian Cancer. J Cancer Sci Therapy 6, 422–428 (2014)CrossRef
104.
A. Shen, L. Wang, M. Huang, J. Sun, Y. Chen, Y.Y. Shen, X. Yang, X. Wang, J. Ding, M. Geng, C-Myc alterations confer therapeutic response and acquired resistance to c-met inhibitors in MET-addicted cancers. Cancer Res 75, 4548–4559 (2015)PubMedCrossRef
105.
X.N. Pan, J.J. Chen, L.X. Wang, R.Z. Xiao, L.L. Liu, Z.G. Fang, Q. Liu, Z.J. Long, D.J. Lin, Inhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiation. PLoS One 9, e105381 (2014)PubMedPubMedCentralCrossRef
106.
L.H. Yan, X.T. Wang, J. Yang, F.B. Kong, C. Lian, W.Y. Wei, W. Luo, Y.B. Xie, Q. Xiao, Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. J Cell Biochem 115, 34–41 (2014)PubMedCrossRef
107.
M.T. Rosenfeldt, L.A. Bell, J.S. Long, J. O'Prey, C. Nixon, F. Roberts, C. Dufès, K.M. Ryan, E2F1 drives chemotherapeutic drug resistance via ABCG2. Oncogene 33, 4164–4172 (2014)PubMedCrossRef
108.
J.J. Stevens, B. Graham, E. Dugo, B. Berhaneselassie-Sumner, K. Ndebele, P.B. Tchounwou, Arsenic trioxide induces apoptosis via specific signaling pathways in HT-29 colon cancer cells. J Cancer Sci Therapy 9, 298–306 (2017)CrossRef
109.
J.B. Bell, F. Eckerdt, H.D. Dhruv, D. Finlay, S. Peng, S. Kim, B. Kroczynska, E.M. Beauchamp, K. Alley, J. Clymer, S. Goldman, S.Y. Cheng, C.D. James, I. Nakano, C. Horbinski, A.P. Mazar, K. Vuori, P. Kumthekar, J. Raizer, M.E. Berens, L.C. Platanias, Differential response of glioma stem cells to arsenic trioxide therapy is regulated by MNK1 and mRNA translation. Mol Cancer Res 16, 32–46 (2018)PubMedCrossRef
110.
111.
Z. Li et al., The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death Diff 24, 59–71 (2017)CrossRef
112.
H. Kurihara, R. Maruyama, K. Ishiguro, S. Kanno, I. Yamamoto, K. Ishigami, K. Mitsuhashi, H. Igarashi, M. Ito, T. Tanuma, Y. Sukawa, K. Okita, T. Hasegawa, K. Imai, H. Yamamoto, Y. Shinomura, K. Nosho, The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Oncotarget 7, 12704–12717 (2016)PubMedPubMedCentralCrossRef
113.
A.P. Russell, S. Lamon, H. Boon, S. Wada, I. Güller, E.L. Brown, A.V. Chibalin, J.R. Zierath, R.J. Snow, N. Stepto, G.D. Wadley, T. Akimoto, Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training. J Physiol 591, 4637–4653 (2013)PubMedPubMedCentralCrossRef
114.
B. Kunkle, Q. Felty, G. Narasimhan, F. Trevino, D. Roy. Meta-analysis of brain tumor microarray data using Oncomine identifies NRF1, TFAM and MYC co-expressed genes: Its implications in the development of childhood brain tumors. 18th World IMACS / MODSIM Congress, Cairns, Australia 720–726 (2009)
115.
W.R. Taylor, A.H. Schonthal, J. Galante, G.R. Stark, p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J Biol Chem 276, 1998–2006 (2001)PubMedCrossRef
116.
T.L. Born, J.A. Frost, A. Schönthal, G.C. Prendergast, J.R. Feramisco, C-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol 14, 5710–5718 (1994)PubMedPubMedCentralCrossRef
117.
I.B. Rosenwald, D.B. Rhoads, L.D. Callanan, K.J. Isselbacher, E.V. Schmidt, Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2a in response to growth induction by c-myc. Proc Natl Acad Sci U S A 90, 6175–6178 (1993)PubMedPubMedCentralCrossRef
118.
V.O. Okoh, Q. Felty, J. Parkash, R. Poppiti, D. Roy, Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One 8, e54206 (2013)PubMedPubMedCentralCrossRef
119.
M.V. Oli, M.M. Grober, G. Giurato, M. Ravo, L. Cicatiello, M.R.D. Filippo, L. Ferraro, G. Nassa, M.F. Papa, O. Paris, R. Tarallo, S. Luo, G.P. Schroth, V.B.A. Weisz, Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 12, 1471–2164 (2011)
120.
I. Riz, R.G. Hawley, G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene 24, 5561–5575 (2005)PubMedPubMedCentralCrossRef
121.
R. Tongbai, G. Idelman, S.H. Nordgard, W. Cui, J.L. Jacobs, C.M. Haggerty, S.J. Chanock, A.L. Borrensen-Dale, G. Livingston, P. Shaunessy, C.H. Chiang, V.N. Kristensen, S. Bilke, K. Gardner, Transcriptional networks inferred from molecular signatures of breast cancer. Am J Pathol 172, 495–509 (2008)PubMedPubMedCentralCrossRef
122.
F. Li, Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, K.A. O’Donnell, J.W. Kim, J.T. Yustein, L.A. Lee, C.V. Dang, Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25, 6225–6234 (2005)PubMedPubMedCentralCrossRef
123.
R. Elkon, K.I. Zeller, C. Linhart, C.V. Dang, R. Shamir, Y. Shiloh, In silico identification of transcriptional regulators associated with c-Myc. Nucleic Acids Res 32, 4955–4961 (2004)PubMedPubMedCentralCrossRef
124.
M. Collu-Marchese, M. Shuen, M. Pauly, A. Saleem, D.A. Hood, The regulation of mitochondrial transcription factor a (Tfam) expression during skeletal muscle cell differentiation. Biosci Rep 35, e00221 (2015)PubMedPubMedCentral
125.
M. Lynch, L. Chen, M.J. Ravitz, S. Mehtani, K. Korenblat, M.J. Pazin, E.V. Schmidt, hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol 25, 6436–6453 (2005)PubMedPubMedCentralCrossRef
126.
L. Zhang, H. Yu, P. Wang, Q. Ding, Z. Wang, Screening of transcription factors with transcriptional initiation activity. Gene 531, 64–70 (2013)PubMedCrossRef
127.
128.
129.
M.R. Doe, J.M. Ascano, M. Kaur, M.D. Cole, Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Res 72, 949–957 (2012)PubMedCrossRef
130.
B.-K. Lee, A.A. Bhinge, V.R. Iyer, Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis. Nucleic Acids Res 39, 3558–3573 (2011)PubMedPubMedCentralCrossRef
131.
S. Terry, S. Buart, T.Z. Tan, G. Gros, M.Z. Noman, J.B. Lorens, F. Mami-Chouaib, J.P. Thiery, S. Chouaib, Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity. OncoImmunology 6, 2 (2017)CrossRef
132.
S. Moniz, D. Bandarra, J. Biddlestone, K.J. Campbell, D. Komander, A. Bremm, S. Rocha, Cezanne regulates E2F1-dependent HIF2α expression. J Cell Sci 128, 3082–3093 (2015)PubMedPubMedCentralCrossRef
133.
S.T. Shors, J.S.E. Bassey, S.J. Harkin, B. Safer, Formation of alpha-pal/max heterodimers synergistically activates the eIF2-alpha promoter. J Biol Chem 273, 34703–34709 (1998)PubMedCrossRef
134.
D. Kumari, A. Gabrielian, D. Wheeler, K. Usdin, The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the fragile X mental retardation gene promoter. Biochem J 386, 297–303 (2005)PubMedPubMedCentralCrossRef
135.
D.E. Fisher, L.A. Parent, P.A. Sharp, Myc/max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. Proc Natl Acad Sci U S A 89, 11779–11783 (1992)PubMedPubMedCentralCrossRef
Metadaten
Titel
Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression
verfasst von
Kaumudi Bhawe
Deodutta Roy
Publikationsdatum
25.07.2018
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 5/2018
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-018-0395-3

Weitere Artikel der Ausgabe 5/2018

Cellular Oncology 5/2018 Zur Ausgabe

Original Paper

Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk

Original Paper

Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells

Original Paper

Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation

Original Paper

Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis

Original Paper

β-Catenin gene promoter hypermethylation by reactive oxygen species correlates with the migratory and invasive potentials of colon cancer cells

Original Paper

Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Open Access 22.02.2024 | Pathologie | Originalien

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

21.02.2024 | Thrombozytopenie | CME

Knochenmarkhistologie bei Zytopenien
Beitrag zur hämatologischen Differenzialdiagnostik

Open Access 21.02.2024 | Fettleber | Originalien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien
Automatische Quantifizierung von Leberverfettung